Shopping Cart 0
Cart Subtotal
USD 0

Antithrombotic Drugs Global Market Opportunities And Strategies To 2030

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8000

Details

This report describes and evaluates the global antithrombotic drugs market. It covers one five-year period, two four-year periods and one six-year period including, 2015 to 2019, termed the historic period, and 2019 to 2022 forecast period, 2022-2025 forecast period and 2025 -2030 the forecast period.
 
The global antithrombotic drugs market reached a value of nearly USD 35,801.9 million in 2019, having grown at a compound annual growth rate (CAGR) of 9.8% since 2015, and is expected to grow at a CAGR of 7.7% to nearly USD 44,702.6 million by 2022.Also the market is expected to growth to USD 55,172.2 million in 2025 at a CAGR of 7.3% and to USD 72,996.5 million in 2030 at a CAGR of 5.8%.
 
Growth in the historic period resulted from aging population and emerging markets. Factors that negatively affected growth in the historic period were patent expiry of drugs, pricing, high costs of drug approval.
 
Going forward, busy life styles, technology and faster economic growth is expected to drive the market. Factor that could hinder the growth of the antithrombotic drugs market in the future include pricing pressures and side effects of antithrombotic drugs.
 
The antithrombotic drugs market is segmented by type of product into anti-coagulant drugs, anti-fibrinolytics drugs and anti-platelet drugs. The anticoagulant drugs market was the largest segment of the antithrombotic drugs market, accounting for USD 19,536.3 million or 54.6% of the total market in 2019. The antiplatelet drugs market is expected to be the fastest-growing segment going forward at a CAGR of 8.7%.
 
The antithrombotic drugs market is segmented by type of application into hyperlipidemia treatment, blood clot and thromboembolic treatment drugs, prophylactic treatment and other applications. The blood clot and thromboembolic treatment drugs was the largest and fastest growing segment of the antithrombotic drugs market by application, accounting for USD 12,844.2 million or 35.9% of the total market in 2019.
 
The antithrombotic drugs market is segmented by drug class into heparin, apixaban, rivaroxaban, dabigatran, fondaparinux, and others. The heparin was the largest segment of the antithrombotic drugs market by drug class, accounting for USD 13,809.1 million or 38.6% of the total market in 2019. The apixaban market is expected to be the fastest-growing segment going forward at a CAGR of 12.5%.
 
The antithrombotic drugs market is segmented by route of administration into oral and parenteral route. The oral was largest segment of the antithrombotic drugs market, accounting for USD 25,362.5 million or 70.8% of the total market in 2019, and is expected to be the fastest-growing segment going forward at a CAGR of 8.2%.
 
The antithrombotic drugs market is segmented by distribution channel into general pharmacies, hospital pharmacies and online retailers. The general pharmacies was largest segment of the antithrombotic drugs market, accounting for USD 22,284.3 million or 62.2% of the total market in 2019. The online retailers' distribution channel is expected to be the fastest-growing segment going forward at a CAGR of 13.0%.
 
Asia-Pacific was the largest region in the antithrombotic drugs market, accounting for 36.1% of the global market in 2019. It was followed by North America, Western Europe and the other regions. Going forward, the fastest growing regions in the antithrombotic drugs market will be Asia-Pacific and the Middle East, where growth will be at CAGRs of 10.7% and 8.0% respectively from 2019-2022.
 
The global antithrombotic drugs market is fairly concentrated, with a small number of large players. The top ten competitors in the market made up to 62% of the total market in 2018. Major players in the market include Bristol Myers Squibb, Bayer AG, Pfizer, Johnson & Johnson, Boehringer-Ingelheim and others.
 
The top growth potential in the antithrombotic drugs market will arise in anti-coagulant drugs market, which will gain USD 4,859.6 million of global annual sales by 2022. The antithrombotic drugs market size will gain the most in China at USD 2,674.0 million.
 
Market-trend-based strategies for the antithrombotic drugs market include developing effective therapies that replace traditional therapies, developing tranexamic acid drug and new patented drugs to offer improved treatment to thrombosis patients. Player-adopted strategies in the antithrombotic drugs industry include strengthening portfolio through mergers and acquisitions and investing in research and development for development of new drug regimen for thrombotic conditions.
READ MORE

Table Of Content

Scope

1. Antithrombotic Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Antithrombotic Drugs Market Characteristics

6.1. Market Segmentation By Type Of Product

6.1.1. Anticoagulant Drugs

6.1.2. Antiplatelet Drugs

6.1.3. Thrombolytic Drugs

6.2. Market Segmentation By Application

6.2.1. Blood Clot And Thromboembolic Treatment

6.2.2. Hyperlipidemia Treatment

6.2.3. Prophylactic Treatment

6.2.4. Other Applications

6.3. Market Segmentation By Class

6.3.1. Fondaparinux

6.3.2. Heparin

6.3.3. Apixaban

6.3.4. Dabigatran

6.3.5. Rivaroxaban

6.3.6. Others

6.4. Market Segmentation By Route Of Administration

6.4.1. Oral

6.4.2. Parenteral

6.5. Market Segmentation By Distribution Channel

6.5.1. Hospital Pharmacies

6.5.2. Online Retailers

6.5.3. Drug Stores

7. Global Antithrombotic Drugs Market Size And Growth

7.1. Historic And Forecast Market Growth, Value (USD Million)

7.1.1. Historic Drivers Of The Market 2015-2019

7.1.2. Historic Restraints Of The Market 2015-2019

7.1.3. Forecast Drivers Of The Market 2019-2022

7.1.4. Forecast Restraints Of The Market 2019-2022

8. Global Antithrombotic Drugs Market Segmentation

8.1. Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

8.2. Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

8.3. Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

8.4. Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

8.5. Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

9. Antithrombotic Drugs Market, Regional And Country Analysis

9.1. Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

9.2. Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10. Asia-Pacific Antithrombotic Drugs Market

10.1.Asia-Pacific Antithrombotic Drugs Market Overview

10.1.1. Region Information

10.1.2. Market Information

10.1.3. Background Information

10.1.4. New Drug Approvals

10.1.5. Government Initiatives

10.1.6. Regulatory Bodies

10.1.7. Regulations

10.1.8. Associations

10.1.9. Taxes Levied

10.1.10. Corporate Tax

10.1.11. Investments

10.1.12. Major Companies

10.2.Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.3.Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.4.Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.5.Asia-Pacific Antithrombotic Drugs Market: Country Analysis

10.6.China Antithrombotic Drugs Market

10.7.China Antithrombotic Drugs Market Overview

10.7.1. Country Information

10.7.2. Market Information

10.7.3. Background Information

10.7.4. New Drug Approvals

10.7.5. Government Initiatives

10.7.6. Regulatory Bodies

10.7.7. Regulations

10.7.8. Associations

10.7.9. Taxes Levied

10.7.10. Corporate Tax

10.7.11. Investments

10.7.12. Major Companies

10.8.China Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.9.China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.10. China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.11. India Antithrombotic Drugs Market

10.12. India Antithrombotic Drugs Market Overview

10.12.1. Country Information

10.12.2. Market Information

10.12.3. Background Information

10.12.4. New Drug Approvals

10.12.5. Government Initiatives

10.12.6. Regulatory Bodies

10.12.7. Regulations

10.12.8. Associations

10.12.9. Taxes Levied

10.12.10. Corporate Tax

10.12.11. Investments

10.12.12. Major Companies

10.13. India Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.14. India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.15. India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.16. Japan Antithrombotic Drugs Market

10.17. Japan Antithrombotic Drugs Market Overview

10.17.1. Region Information

10.17.2. Market Information

10.17.3. Background Information

10.17.4. Government Initiatives

10.17.5. Regulatory Bodies

10.17.6. Regulations

10.17.7. Associations

10.17.8. Taxes Levied

10.17.9. Corporate Tax

10.17.10. Investments

10.17.11. Major Companies

10.18. Japan Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.19. Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.20. Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.21. Australia Antithrombotic Drugs Market

10.22. Australia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.23. Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.24. Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.25. Indonesia Antithrombotic Drugs Market

10.26. Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.27. Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.28. Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.29. South Korea Antithrombotic Drugs Market

10.30. South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.31. South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.32. South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11. Western Europe Antithrombotic Drugs Market

11.1.Western Europe Antithrombotic Drugs Market Overview

11.1.1. Region Information

11.1.2. Market Information

11.1.3. Background Information

11.1.4. New Drug Approvals

11.1.5. Government Initiatives

11.1.6. Regulatory Bodies

11.1.7. Regulations

11.1.8. Associations

11.1.9. Taxes Levied

11.1.10. Corporate Tax

11.1.11. Investments

11.1.12. Major Companies

11.2.Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

11.3.Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.4.Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.5.Western Europe Antithrombotic Drugs Market: Country Analysis

11.6.UK Antithrombotic Drugs Market

11.7.UK Antithrombotic Drugs Market Overview

11.7.1. Region Information

11.7.2. Market Information

11.7.3. Background Information

11.7.4. New Drug Approvals

11.7.5. Government Initiatives

11.7.6. Regulatory Bodies

11.7.7. Regulations

11.7.8. Associations

11.7.9. Taxes Levied

11.7.10. Corporate Tax

11.7.11. Investments

11.7.12. Major Companies

11.8.UK Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

11.9.UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.10. UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.11. Germany Antithrombotic Drugs Market

11.12. Germany Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

11.13. Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.14. Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.15. France Antithrombotic Drugs Market

11.16. France Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

11.17. France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.18. France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

12. Eastern Europe Antithrombotic Drugs Market

12.1.Eastern Europe Antithrombotic Drugs Market Overview

12.1.1. Region Information

12.1.2. Market Information

12.1.3. Background Information

12.1.4. New Drug Approvals

12.1.5. Government Initiatives

12.1.6. Regulatory Bodies

12.1.7. Regulations

12.1.8. Associations

12.1.9. Taxes Levied

12.1.10. Corporate Tax

12.1.11. Investments

12.1.12. Major Companies

12.2.Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

12.3.Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

12.4.Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

12.5.Eastern Europe Antithrombotic Drugs Market: Country Analysis

12.6.Russia Antithrombotic Drugs Market

12.7.Russia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

12.8.Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

12.9.Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

13. North America Antithrombotic Drugs Market

13.1.North America Antithrombotic Drugs Market Overview

13.1.1. Region Information

13.1.2. Market Information

13.1.3. Background Information

13.1.4. New Drug Approvals

13.1.5. Government Initiatives

13.1.6. Regulatory Bodies

13.1.7. Regulations

13.1.8. Associations

13.1.9. Taxes Levied

13.1.10. Corporate Tax

13.1.11. Investments

13.1.12. Major Companies

13.2.North America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

13.3.North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

13.4.North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

13.5.North America Antithrombotic Drugs Market: Country Analysis

13.6.USA Antithrombotic Drugs Market

13.7.USA Antithrombotic Drugs Market Overview

13.7.1. Country Information

13.7.2. Market Information

13.7.3. Background Information

13.7.4. New Drug Approvals

13.7.5. Government Initiatives

13.7.6. Regulatory Bodies

13.7.7. Regulations

13.7.8. Associations

13.7.9. Taxes Levied

13.7.10. Corporate Tax

13.7.11. Investments

13.7.12. Major Companies

13.8.USA Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

13.9.USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

13.10. USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

14. South America Antithrombotic Drugs Market

14.1.South America Antithrombotic Drugs Market Overview

14.1.1. Region Information

14.1.2. Market Information

14.1.3. Background Information

14.1.4. Government Initiatives

14.1.5. Regulatory Bodies

14.1.6. Regulations

14.1.7. Associations

14.1.8. Taxes Levied

14.1.9. Corporate Tax

14.1.10. Major Companies

14.2.South America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

14.3.South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

14.4.South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

14.5.South America Antithrombotic Drugs Market: Country Analysis

14.6.Brazil Antithrombotic Drugs Market

14.7.Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

14.8.Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

14.9.Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

15. Middle East Antithrombotic Drugs Market

15.1.Middle East Antithrombotic Drugs Market Overview

15.1.1. Region Information

15.1.2. Market Information

15.1.3. Government Initiatives

15.1.4. Regulatory Bodies

15.1.5. Regulations

15.1.6. Associations

15.1.7. Taxes Levied

15.1.8. Corporate Tax

15.1.9. Investments

15.1.10. Major Companies

15.2.Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

15.3.Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

15.4.Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

16. Africa Antithrombotic Drugs Market

16.1.Africa Antithrombotic Drugs Market Overview

16.1.1. Region Information

16.1.2. Market Information

16.1.3. Government Initiatives

16.1.4. Regulatory Bodies

16.1.5. Regulations

16.1.6. Associations

16.1.7. Taxes Levied

16.1.8. Corporate Tax

16.1.9. Major Companies

16.2.Africa Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

16.3.Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

16.4.Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

17. Global Antithrombotic Drugs Market Competitive Landscape

17.1.Company Profiles

17.2.Bristol Myers Squibb

17.2.1. Company Overview

17.2.2. Products And Services

17.2.3. Business Strategy

17.2.4. Financial Overview

17.3.Bayer AG

17.3.1. Company Overview

17.3.2. Products And Services

17.3.3. Business Strategy

17.3.4. Financial Overview

17.4.Pfizer

17.4.1. Company Overview

17.4.2. Products And Services

17.4.3. Business Strategy

17.4.4. Financial Overview

17.5.Johnson & Johnson

17.5.1. Company Overview

17.5.2. Products And Services

17.5.3. Business Strategy

17.5.4. Financial Overview

17.6.Boehringer-Ingelheim GmbH

17.6.1. Company Overview

17.6.2. Products And Services

17.6.3. Business Strategy

17.6.4. Financial Overview

18. Key Mergers And Acquisitions In The Antithrombotic Drugs Market

18.1.AMAG Pharmaceuticals Acquired Perosphere Pharmaceuticals

18.2.Johnson & Johnson Acquired Bristol-Myers Cardiovascular Disease Program

18.3.Sanofi Acquired Bioverativ Inc.

18.4.AstraZeneca Acquired Antithrombotic Candidate From APT Therapeutics

18.5.Bristol-Myers Acquired Cardioxyl's Heart Failure Therapy

18.6.Janssen Acquired XO1 Limited

19. Antithrombotic Drugs Market Trends And Strategies

19.1.Novel Oral Anti-coagulants(NOACs) To Prevent Thrombosis

19.2.Tranexamic Acid To Prevent Postpartum Hemorrhage

19.3.New Antithrombotic Biologics To Cure Blood Vessel Wall Injury

20. Antithrombotic Drugs Market, Product Pipeline Analysis

21. Antithrombotic Drugs Market Future Outlook and Potential Analysis

21.1.Global Antithrombotic Drugs Market In 2022-Countries Offering Most New Opportunities

21.2.Global Antithrombotic Drugs Market In 2022- Segments Offering Most New Opportunities

21.3.Global Antithrombotic Drugs Market In 2022-Growth Strategies

21.3.1. Market Trend Based Strategies

21.3.2. Competitor Strategies

22. AntithromboticDrugs Market, Conclusions And Recommendations

22.1.Conclusions

22.2.Recommendations

22.2.1. Product

22.2.2. Price

22.2.3. Place

22.2.4. Promotion

23. Appendix

23.1.Market Data Sources

23.2.Research Methodology

23.3.Currencies

23.4.Research Inquiries

23.5.The Business Research Company

24. Copyright and Disclaimer


List Of Figure

Figure 1: Global Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 2: Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 3: Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 4: Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 5: Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 6: Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 7: Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 8: Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 9: Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 10: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 11: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 12: China Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 13: China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 14: China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 15: India Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 16: India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 17: India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 18: Japan Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 19: Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 20: Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 21: Australia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 22: Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 23: Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 24: Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 25: Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 26: Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 27: South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 28: South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 29: South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 30: Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 31: Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 32: Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 33: UK Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 34: UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 35: UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 36: Germany Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 37: Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 38: Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 39: France Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 40: France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 41: France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 42: Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 43: Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 44: Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 45: Russia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 46: Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 47: Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 48: North America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 49: North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 50: North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 51: USA Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 52: USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 53: USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 54: South America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 55: South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 56: South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 57: Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 58: Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 59: Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 60: Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 61: Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 62: Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 63: Africa Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 64: Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 65: Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 66: Global Antithrombotic Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)

Figure 67: Bristol Myers Squibb-Financial Performance, 2015-2019, USD Billion

Figure 68: Bayer AG-Financial Performance, 2015-2019, USD Billion

Figure 69: Pfizer- Financial Performance, 2015-2019, USD Billion

Figure 70: Johnson & Johnson (J&J)- Financial Performance, 2014-2018,USD Billion

Figure 71: Boehringer Ingelheim GmbH-Financial Performance, USD Billion


List Of Table

Table 1: Global Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 2: Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 3: Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 4: Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 5: Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 6: Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 7: Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 8: Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 9: Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 10: Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 11: Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 12: Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 13: Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 14: Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 15: Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 16: Asia-Pacific, Prevalence Of Rheumatic Heart Disease, 2014-2017

Table 17: Asia-Pacific, Ischemic Heart Disease, 2014-2017

Table 18: Asia-Pacific, Prevalence Of Ischemic Stroke, 2014-2017

Table 19: Asia-Pacific, Intracerebral Hemorrhage, 2014-2017

Table 20: Asia-Pacific, Prevalence Of Subarachnoid Hemorrhage, 2014-2017

Table 21: Asia-Pacific, Prevalence Of Non-Rheumatic Calcific Aortic Valve Disease, 2014-2017

Table 22: Asia-Pacific, Prevalence Of Myocarditis, 2014-2017

Table 23: Asia-Pacific, Prevalence Of Rheumatic Heart Disease, 2014-2017

Table 24: Asia-Pacific, Prevalence Of Other Cardiovascular And Circulatory Diseases, 2014-2017

Table 25: Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 26: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 27: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 28: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 29: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 30: China, Prevalence Of Thrombotic Conditions, 2014-2017

Table 31: China Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 32: China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 33: China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 34: China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 35: China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 36: India, Prevalence Of Thrombotic Conditions, 2014-2017

Table 37: India Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 38: India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 39: India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 40: India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 41: India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 42: Japan, Prevalence Of Thrombotic Conditions, 2014-2017

Table 43: Japan Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 44: Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 45: Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 46: Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 47: Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 48: Australia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 49: Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 50: Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 51: Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 52: Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 53: Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 54: Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 55: Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 56: Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 57: Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 58: South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 59: South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 60: South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 61: South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 62: South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 63: Western Europe, Prevalence Of Rheumatic Heart Disease, 2014-2017

Table 64: Western Europe, Ischemic Heart Disease, 2014-2017

Table 65: Western Europe, Prevalence Of Ischemic Stroke, 2014-2017

Table 66: Western Europe, Intracerebral Hemorrhage, 2014-2017

Table 67: Western Europe, Prevalence Of Subarachnoid Hemorrhage, 2014-2017

Table 68: Western Europe, Prevalence Of Non-Rheumatic Calcific Aortic Valve Disease, 2014-2017

Table 69: Western Europe, Prevalence Of Myocarditis, 2014-2017

Table 70: Western Europe, Prevalence Of Rheumatic Heart Disease, 2014-2017

Table 71: Western Europe, Prevalence Of Other Cardiovascular And Circulatory Diseases, 2014-2017

Table 72: Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 73: Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 74: Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 75: Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 76: Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 77: UK, Prevalence Of Thrombotic Conditions, 2014-2017

Table 78: UK Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 79: UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 80: UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 81: UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 82: UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 83: Germany Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 84: Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 85: Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 86: Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 87: Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 88: France Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 89: France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 90: France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 91: France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 92: France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 93: Russia, Prevalence Of Thrombotic Conditions, 2014-2017

Table 94: Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 95: Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 96: Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 97: Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 98: Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 99: Russia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 100: Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 101: Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 102: Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 103: Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 104: USA, Prevalence Of Thrombotic Conditions, 2014-2017

Table 105: North America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 106: North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 107: North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 108: North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 109: North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 110: USA, Prevalence Of Thrombotic Conditions, 2014-2017

Table 111: USA Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 112: USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 113: USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 114: USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 115: USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 116: Brazil, Prevalence Of Thrombotic Conditions, 2014-2017

Table 117: South America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 118: South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 119: South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 120: South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 121: South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 122: Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 123: Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 124: Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 125: Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 126: Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 127: Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 128: Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 129: Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 130: Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 131: Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 132: Africa Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 133: Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 134: Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 135: Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 136: Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 137: Global Antithrombotic Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)

Table 138: Bristol Myers Squibb-Financial Performance, 2015-2019, USD Billion

Table 139: Bayer AG-Financial Performance, 2015-2019, USD Billion

Table 140: Pfizer- Financial Performance, 2015-2019, USD Billion

Table 141: Johnson & Johnson (J&J)- Financial Performance, 2014-2018, USD Billion

Table 142: Boehringer Ingelheim GmbH-Financial Performance, USD Billion

Table 143: Global Antithrombotic Drugs Market, Product Pipeline Analysis

Table 144: Antithrombotic Drugs Market Size Gain (USD Million), 2019-2022, By Country

Table 145: Antithrombotic Drugs Market Size Gain (USD Million), 2019-2022, By Type

Table 146: Antithrombotic Drugs Market Size Gain (USD Million), 2019-2022, By Application Type

Table 147: Antithrombotic Drugs Market Data Sources

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

By Type Of Product: Anticoagulant Drugs; Antiplatelet Drugs; Thrombolytic Drugs By Application: Blood Clot And Thromboembolic Treatment; Hyperlipidemia Treatment; Prophylactic Treatment; Other Applications By Class: Fondaparinux; Heparin; Apixaban; Dabigatran; Rivaroxaban; Others By Route Of Administration: Oral Route; Parenteral Route By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers


Companies

Bristol Myers Squibb; Bayer AG; Pfizer; Johnson & Johnson; Boehringer-Ingelheim

Company Profile

Company Profile Title

This report describes and evaluates the global antithrombotic drugs market. It covers one five-year period, two four-year periods and one six-year period including, 2015 to 2019, termed the historic period, and 2019 to 2022 forecast period, 2022-2025 forecast period and 2025 -2030 the forecast period.
 
The global antithrombotic drugs market reached a value of nearly USD 35,801.9 million in 2019, having grown at a compound annual growth rate (CAGR) of 9.8% since 2015, and is expected to grow at a CAGR of 7.7% to nearly USD 44,702.6 million by 2022.Also the market is expected to growth to USD 55,172.2 million in 2025 at a CAGR of 7.3% and to USD 72,996.5 million in 2030 at a CAGR of 5.8%.
 
Growth in the historic period resulted from aging population and emerging markets. Factors that negatively affected growth in the historic period were patent expiry of drugs, pricing, high costs of drug approval.
 
Going forward, busy life styles, technology and faster economic growth is expected to drive the market. Factor that could hinder the growth of the antithrombotic drugs market in the future include pricing pressures and side effects of antithrombotic drugs.
 
The antithrombotic drugs market is segmented by type of product into anti-coagulant drugs, anti-fibrinolytics drugs and anti-platelet drugs. The anticoagulant drugs market was the largest segment of the antithrombotic drugs market, accounting for USD 19,536.3 million or 54.6% of the total market in 2019. The antiplatelet drugs market is expected to be the fastest-growing segment going forward at a CAGR of 8.7%.
 
The antithrombotic drugs market is segmented by type of application into hyperlipidemia treatment, blood clot and thromboembolic treatment drugs, prophylactic treatment and other applications. The blood clot and thromboembolic treatment drugs was the largest and fastest growing segment of the antithrombotic drugs market by application, accounting for USD 12,844.2 million or 35.9% of the total market in 2019.
 
The antithrombotic drugs market is segmented by drug class into heparin, apixaban, rivaroxaban, dabigatran, fondaparinux, and others. The heparin was the largest segment of the antithrombotic drugs market by drug class, accounting for USD 13,809.1 million or 38.6% of the total market in 2019. The apixaban market is expected to be the fastest-growing segment going forward at a CAGR of 12.5%.
 
The antithrombotic drugs market is segmented by route of administration into oral and parenteral route. The oral was largest segment of the antithrombotic drugs market, accounting for USD 25,362.5 million or 70.8% of the total market in 2019, and is expected to be the fastest-growing segment going forward at a CAGR of 8.2%.
 
The antithrombotic drugs market is segmented by distribution channel into general pharmacies, hospital pharmacies and online retailers. The general pharmacies was largest segment of the antithrombotic drugs market, accounting for USD 22,284.3 million or 62.2% of the total market in 2019. The online retailers' distribution channel is expected to be the fastest-growing segment going forward at a CAGR of 13.0%.
 
Asia-Pacific was the largest region in the antithrombotic drugs market, accounting for 36.1% of the global market in 2019. It was followed by North America, Western Europe and the other regions. Going forward, the fastest growing regions in the antithrombotic drugs market will be Asia-Pacific and the Middle East, where growth will be at CAGRs of 10.7% and 8.0% respectively from 2019-2022.
 
The global antithrombotic drugs market is fairly concentrated, with a small number of large players. The top ten competitors in the market made up to 62% of the total market in 2018. Major players in the market include Bristol Myers Squibb, Bayer AG, Pfizer, Johnson & Johnson, Boehringer-Ingelheim and others.
 
The top growth potential in the antithrombotic drugs market will arise in anti-coagulant drugs market, which will gain USD 4,859.6 million of global annual sales by 2022. The antithrombotic drugs market size will gain the most in China at USD 2,674.0 million.
 
Market-trend-based strategies for the antithrombotic drugs market include developing effective therapies that replace traditional therapies, developing tranexamic acid drug and new patented drugs to offer improved treatment to thrombosis patients. Player-adopted strategies in the antithrombotic drugs industry include strengthening portfolio through mergers and acquisitions and investing in research and development for development of new drug regimen for thrombotic conditions.
READ MORE

Scope

1. Antithrombotic Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Antithrombotic Drugs Market Characteristics

6.1. Market Segmentation By Type Of Product

6.1.1. Anticoagulant Drugs

6.1.2. Antiplatelet Drugs

6.1.3. Thrombolytic Drugs

6.2. Market Segmentation By Application

6.2.1. Blood Clot And Thromboembolic Treatment

6.2.2. Hyperlipidemia Treatment

6.2.3. Prophylactic Treatment

6.2.4. Other Applications

6.3. Market Segmentation By Class

6.3.1. Fondaparinux

6.3.2. Heparin

6.3.3. Apixaban

6.3.4. Dabigatran

6.3.5. Rivaroxaban

6.3.6. Others

6.4. Market Segmentation By Route Of Administration

6.4.1. Oral

6.4.2. Parenteral

6.5. Market Segmentation By Distribution Channel

6.5.1. Hospital Pharmacies

6.5.2. Online Retailers

6.5.3. Drug Stores

7. Global Antithrombotic Drugs Market Size And Growth

7.1. Historic And Forecast Market Growth, Value (USD Million)

7.1.1. Historic Drivers Of The Market 2015-2019

7.1.2. Historic Restraints Of The Market 2015-2019

7.1.3. Forecast Drivers Of The Market 2019-2022

7.1.4. Forecast Restraints Of The Market 2019-2022

8. Global Antithrombotic Drugs Market Segmentation

8.1. Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

8.2. Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

8.3. Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

8.4. Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

8.5. Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

9. Antithrombotic Drugs Market, Regional And Country Analysis

9.1. Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

9.2. Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10. Asia-Pacific Antithrombotic Drugs Market

10.1.Asia-Pacific Antithrombotic Drugs Market Overview

10.1.1. Region Information

10.1.2. Market Information

10.1.3. Background Information

10.1.4. New Drug Approvals

10.1.5. Government Initiatives

10.1.6. Regulatory Bodies

10.1.7. Regulations

10.1.8. Associations

10.1.9. Taxes Levied

10.1.10. Corporate Tax

10.1.11. Investments

10.1.12. Major Companies

10.2.Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.3.Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.4.Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.5.Asia-Pacific Antithrombotic Drugs Market: Country Analysis

10.6.China Antithrombotic Drugs Market

10.7.China Antithrombotic Drugs Market Overview

10.7.1. Country Information

10.7.2. Market Information

10.7.3. Background Information

10.7.4. New Drug Approvals

10.7.5. Government Initiatives

10.7.6. Regulatory Bodies

10.7.7. Regulations

10.7.8. Associations

10.7.9. Taxes Levied

10.7.10. Corporate Tax

10.7.11. Investments

10.7.12. Major Companies

10.8.China Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.9.China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.10. China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.11. India Antithrombotic Drugs Market

10.12. India Antithrombotic Drugs Market Overview

10.12.1. Country Information

10.12.2. Market Information

10.12.3. Background Information

10.12.4. New Drug Approvals

10.12.5. Government Initiatives

10.12.6. Regulatory Bodies

10.12.7. Regulations

10.12.8. Associations

10.12.9. Taxes Levied

10.12.10. Corporate Tax

10.12.11. Investments

10.12.12. Major Companies

10.13. India Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.14. India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.15. India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.16. Japan Antithrombotic Drugs Market

10.17. Japan Antithrombotic Drugs Market Overview

10.17.1. Region Information

10.17.2. Market Information

10.17.3. Background Information

10.17.4. Government Initiatives

10.17.5. Regulatory Bodies

10.17.6. Regulations

10.17.7. Associations

10.17.8. Taxes Levied

10.17.9. Corporate Tax

10.17.10. Investments

10.17.11. Major Companies

10.18. Japan Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.19. Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.20. Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.21. Australia Antithrombotic Drugs Market

10.22. Australia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.23. Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.24. Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.25. Indonesia Antithrombotic Drugs Market

10.26. Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.27. Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.28. Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.29. South Korea Antithrombotic Drugs Market

10.30. South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

10.31. South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

10.32. South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11. Western Europe Antithrombotic Drugs Market

11.1.Western Europe Antithrombotic Drugs Market Overview

11.1.1. Region Information

11.1.2. Market Information

11.1.3. Background Information

11.1.4. New Drug Approvals

11.1.5. Government Initiatives

11.1.6. Regulatory Bodies

11.1.7. Regulations

11.1.8. Associations

11.1.9. Taxes Levied

11.1.10. Corporate Tax

11.1.11. Investments

11.1.12. Major Companies

11.2.Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

11.3.Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.4.Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.5.Western Europe Antithrombotic Drugs Market: Country Analysis

11.6.UK Antithrombotic Drugs Market

11.7.UK Antithrombotic Drugs Market Overview

11.7.1. Region Information

11.7.2. Market Information

11.7.3. Background Information

11.7.4. New Drug Approvals

11.7.5. Government Initiatives

11.7.6. Regulatory Bodies

11.7.7. Regulations

11.7.8. Associations

11.7.9. Taxes Levied

11.7.10. Corporate Tax

11.7.11. Investments

11.7.12. Major Companies

11.8.UK Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

11.9.UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.10. UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.11. Germany Antithrombotic Drugs Market

11.12. Germany Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

11.13. Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.14. Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.15. France Antithrombotic Drugs Market

11.16. France Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

11.17. France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

11.18. France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

12. Eastern Europe Antithrombotic Drugs Market

12.1.Eastern Europe Antithrombotic Drugs Market Overview

12.1.1. Region Information

12.1.2. Market Information

12.1.3. Background Information

12.1.4. New Drug Approvals

12.1.5. Government Initiatives

12.1.6. Regulatory Bodies

12.1.7. Regulations

12.1.8. Associations

12.1.9. Taxes Levied

12.1.10. Corporate Tax

12.1.11. Investments

12.1.12. Major Companies

12.2.Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

12.3.Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

12.4.Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

12.5.Eastern Europe Antithrombotic Drugs Market: Country Analysis

12.6.Russia Antithrombotic Drugs Market

12.7.Russia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

12.8.Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

12.9.Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

13. North America Antithrombotic Drugs Market

13.1.North America Antithrombotic Drugs Market Overview

13.1.1. Region Information

13.1.2. Market Information

13.1.3. Background Information

13.1.4. New Drug Approvals

13.1.5. Government Initiatives

13.1.6. Regulatory Bodies

13.1.7. Regulations

13.1.8. Associations

13.1.9. Taxes Levied

13.1.10. Corporate Tax

13.1.11. Investments

13.1.12. Major Companies

13.2.North America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

13.3.North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

13.4.North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

13.5.North America Antithrombotic Drugs Market: Country Analysis

13.6.USA Antithrombotic Drugs Market

13.7.USA Antithrombotic Drugs Market Overview

13.7.1. Country Information

13.7.2. Market Information

13.7.3. Background Information

13.7.4. New Drug Approvals

13.7.5. Government Initiatives

13.7.6. Regulatory Bodies

13.7.7. Regulations

13.7.8. Associations

13.7.9. Taxes Levied

13.7.10. Corporate Tax

13.7.11. Investments

13.7.12. Major Companies

13.8.USA Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

13.9.USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

13.10. USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

14. South America Antithrombotic Drugs Market

14.1.South America Antithrombotic Drugs Market Overview

14.1.1. Region Information

14.1.2. Market Information

14.1.3. Background Information

14.1.4. Government Initiatives

14.1.5. Regulatory Bodies

14.1.6. Regulations

14.1.7. Associations

14.1.8. Taxes Levied

14.1.9. Corporate Tax

14.1.10. Major Companies

14.2.South America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

14.3.South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

14.4.South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

14.5.South America Antithrombotic Drugs Market: Country Analysis

14.6.Brazil Antithrombotic Drugs Market

14.7.Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

14.8.Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

14.9.Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

15. Middle East Antithrombotic Drugs Market

15.1.Middle East Antithrombotic Drugs Market Overview

15.1.1. Region Information

15.1.2. Market Information

15.1.3. Government Initiatives

15.1.4. Regulatory Bodies

15.1.5. Regulations

15.1.6. Associations

15.1.7. Taxes Levied

15.1.8. Corporate Tax

15.1.9. Investments

15.1.10. Major Companies

15.2.Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

15.3.Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

15.4.Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

16. Africa Antithrombotic Drugs Market

16.1.Africa Antithrombotic Drugs Market Overview

16.1.1. Region Information

16.1.2. Market Information

16.1.3. Government Initiatives

16.1.4. Regulatory Bodies

16.1.5. Regulations

16.1.6. Associations

16.1.7. Taxes Levied

16.1.8. Corporate Tax

16.1.9. Major Companies

16.2.Africa Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

16.3.Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

16.4.Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value (USD Million)

17. Global Antithrombotic Drugs Market Competitive Landscape

17.1.Company Profiles

17.2.Bristol Myers Squibb

17.2.1. Company Overview

17.2.2. Products And Services

17.2.3. Business Strategy

17.2.4. Financial Overview

17.3.Bayer AG

17.3.1. Company Overview

17.3.2. Products And Services

17.3.3. Business Strategy

17.3.4. Financial Overview

17.4.Pfizer

17.4.1. Company Overview

17.4.2. Products And Services

17.4.3. Business Strategy

17.4.4. Financial Overview

17.5.Johnson & Johnson

17.5.1. Company Overview

17.5.2. Products And Services

17.5.3. Business Strategy

17.5.4. Financial Overview

17.6.Boehringer-Ingelheim GmbH

17.6.1. Company Overview

17.6.2. Products And Services

17.6.3. Business Strategy

17.6.4. Financial Overview

18. Key Mergers And Acquisitions In The Antithrombotic Drugs Market

18.1.AMAG Pharmaceuticals Acquired Perosphere Pharmaceuticals

18.2.Johnson & Johnson Acquired Bristol-Myers Cardiovascular Disease Program

18.3.Sanofi Acquired Bioverativ Inc.

18.4.AstraZeneca Acquired Antithrombotic Candidate From APT Therapeutics

18.5.Bristol-Myers Acquired Cardioxyl's Heart Failure Therapy

18.6.Janssen Acquired XO1 Limited

19. Antithrombotic Drugs Market Trends And Strategies

19.1.Novel Oral Anti-coagulants(NOACs) To Prevent Thrombosis

19.2.Tranexamic Acid To Prevent Postpartum Hemorrhage

19.3.New Antithrombotic Biologics To Cure Blood Vessel Wall Injury

20. Antithrombotic Drugs Market, Product Pipeline Analysis

21. Antithrombotic Drugs Market Future Outlook and Potential Analysis

21.1.Global Antithrombotic Drugs Market In 2022-Countries Offering Most New Opportunities

21.2.Global Antithrombotic Drugs Market In 2022- Segments Offering Most New Opportunities

21.3.Global Antithrombotic Drugs Market In 2022-Growth Strategies

21.3.1. Market Trend Based Strategies

21.3.2. Competitor Strategies

22. AntithromboticDrugs Market, Conclusions And Recommendations

22.1.Conclusions

22.2.Recommendations

22.2.1. Product

22.2.2. Price

22.2.3. Place

22.2.4. Promotion

23. Appendix

23.1.Market Data Sources

23.2.Research Methodology

23.3.Currencies

23.4.Research Inquiries

23.5.The Business Research Company

24. Copyright and Disclaimer


List Of Figure

Figure 1: Global Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 2: Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 3: Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 4: Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 5: Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 6: Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 7: Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 8: Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 9: Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 10: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 11: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 12: China Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 13: China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 14: China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 15: India Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 16: India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 17: India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 18: Japan Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 19: Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 20: Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 21: Australia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 22: Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 23: Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 24: Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 25: Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 26: Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 27: South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 28: South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 29: South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 30: Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 31: Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 32: Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 33: UK Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 34: UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 35: UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 36: Germany Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 37: Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 38: Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 39: France Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 40: France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 41: France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 42: Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 43: Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 44: Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 45: Russia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 46: Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 47: Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 48: North America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 49: North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 50: North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 51: USA Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 52: USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 53: USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 54: South America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 55: South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 56: South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 57: Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 58: Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 59: Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 60: Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 61: Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 62: Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 63: Africa Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Figure 64: Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 65: Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Figure 66: Global Antithrombotic Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)

Figure 67: Bristol Myers Squibb-Financial Performance, 2015-2019, USD Billion

Figure 68: Bayer AG-Financial Performance, 2015-2019, USD Billion

Figure 69: Pfizer- Financial Performance, 2015-2019, USD Billion

Figure 70: Johnson & Johnson (J&J)- Financial Performance, 2014-2018,USD Billion

Figure 71: Boehringer Ingelheim GmbH-Financial Performance, USD Billion


List Of Table

Table 1: Global Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 2: Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 3: Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 4: Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 5: Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 6: Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 7: Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 8: Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 9: Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 10: Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 11: Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 12: Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 13: Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 14: Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 15: Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 16: Asia-Pacific, Prevalence Of Rheumatic Heart Disease, 2014-2017

Table 17: Asia-Pacific, Ischemic Heart Disease, 2014-2017

Table 18: Asia-Pacific, Prevalence Of Ischemic Stroke, 2014-2017

Table 19: Asia-Pacific, Intracerebral Hemorrhage, 2014-2017

Table 20: Asia-Pacific, Prevalence Of Subarachnoid Hemorrhage, 2014-2017

Table 21: Asia-Pacific, Prevalence Of Non-Rheumatic Calcific Aortic Valve Disease, 2014-2017

Table 22: Asia-Pacific, Prevalence Of Myocarditis, 2014-2017

Table 23: Asia-Pacific, Prevalence Of Rheumatic Heart Disease, 2014-2017

Table 24: Asia-Pacific, Prevalence Of Other Cardiovascular And Circulatory Diseases, 2014-2017

Table 25: Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 26: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 27: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 28: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 29: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 30: China, Prevalence Of Thrombotic Conditions, 2014-2017

Table 31: China Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 32: China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 33: China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 34: China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 35: China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 36: India, Prevalence Of Thrombotic Conditions, 2014-2017

Table 37: India Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 38: India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 39: India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 40: India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 41: India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 42: Japan, Prevalence Of Thrombotic Conditions, 2014-2017

Table 43: Japan Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 44: Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 45: Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 46: Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 47: Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 48: Australia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 49: Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 50: Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 51: Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 52: Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 53: Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 54: Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 55: Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 56: Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 57: Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 58: South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 59: South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 60: South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 61: South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 62: South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 63: Western Europe, Prevalence Of Rheumatic Heart Disease, 2014-2017

Table 64: Western Europe, Ischemic Heart Disease, 2014-2017

Table 65: Western Europe, Prevalence Of Ischemic Stroke, 2014-2017

Table 66: Western Europe, Intracerebral Hemorrhage, 2014-2017

Table 67: Western Europe, Prevalence Of Subarachnoid Hemorrhage, 2014-2017

Table 68: Western Europe, Prevalence Of Non-Rheumatic Calcific Aortic Valve Disease, 2014-2017

Table 69: Western Europe, Prevalence Of Myocarditis, 2014-2017

Table 70: Western Europe, Prevalence Of Rheumatic Heart Disease, 2014-2017

Table 71: Western Europe, Prevalence Of Other Cardiovascular And Circulatory Diseases, 2014-2017

Table 72: Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 73: Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 74: Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 75: Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 76: Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 77: UK, Prevalence Of Thrombotic Conditions, 2014-2017

Table 78: UK Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 79: UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 80: UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 81: UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 82: UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 83: Germany Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 84: Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 85: Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 86: Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 87: Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 88: France Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 89: France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 90: France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 91: France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 92: France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 93: Russia, Prevalence Of Thrombotic Conditions, 2014-2017

Table 94: Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 95: Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 96: Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 97: Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 98: Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 99: Russia Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 100: Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 101: Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 102: Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 103: Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 104: USA, Prevalence Of Thrombotic Conditions, 2014-2017

Table 105: North America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 106: North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 107: North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 108: North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 109: North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 110: USA, Prevalence Of Thrombotic Conditions, 2014-2017

Table 111: USA Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 112: USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 113: USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 114: USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 115: USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 116: Brazil, Prevalence Of Thrombotic Conditions, 2014-2017

Table 117: South America Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 118: South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 119: South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 120: South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 121: South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 122: Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 123: Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 124: Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 125: Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 126: Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 127: Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 128: Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 129: Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 130: Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 131: Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 132: Africa Antithrombotic Drugs Market, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 133: Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 134: Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 135: Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %

Table 136: Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, USD Million

Table 137: Global Antithrombotic Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)

Table 138: Bristol Myers Squibb-Financial Performance, 2015-2019, USD Billion

Table 139: Bayer AG-Financial Performance, 2015-2019, USD Billion

Table 140: Pfizer- Financial Performance, 2015-2019, USD Billion

Table 141: Johnson & Johnson (J&J)- Financial Performance, 2014-2018, USD Billion

Table 142: Boehringer Ingelheim GmbH-Financial Performance, USD Billion

Table 143: Global Antithrombotic Drugs Market, Product Pipeline Analysis

Table 144: Antithrombotic Drugs Market Size Gain (USD Million), 2019-2022, By Country

Table 145: Antithrombotic Drugs Market Size Gain (USD Million), 2019-2022, By Type

Table 146: Antithrombotic Drugs Market Size Gain (USD Million), 2019-2022, By Application Type

Table 147: Antithrombotic Drugs Market Data Sources

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

By Type Of Product: Anticoagulant Drugs; Antiplatelet Drugs; Thrombolytic Drugs By Application: Blood Clot And Thromboembolic Treatment; Hyperlipidemia Treatment; Prophylactic Treatment; Other Applications By Class: Fondaparinux; Heparin; Apixaban; Dabigatran; Rivaroxaban; Others By Route Of Administration: Oral Route; Parenteral Route By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers


Companies

Bristol Myers Squibb; Bayer AG; Pfizer; Johnson & Johnson; Boehringer-Ingelheim